 Janelle Noel-Macdonnell
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 1 | 2018 | 18 | 0.740 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 16 | 0.740 |
Why?
| | Humans | 24 | 2021 | 5729 | 0.590 |
Why?
| | Bronchopulmonary Dysplasia | 3 | 2021 | 80 | 0.560 |
Why?
| | Tracheostomy | 3 | 2021 | 18 | 0.480 |
Why?
| | Retrospective Studies | 12 | 2021 | 1105 | 0.470 |
Why?
| | Female | 14 | 2021 | 3314 | 0.460 |
Why?
| | Lung Diseases | 2 | 2021 | 38 | 0.430 |
Why?
| | Genetic Testing | 2 | 2021 | 73 | 0.410 |
Why?
| | Lung | 2 | 2020 | 90 | 0.390 |
Why?
| | Male | 12 | 2021 | 3249 | 0.340 |
Why?
| | Risk Factors | 7 | 2021 | 398 | 0.320 |
Why?
| | Infant, Newborn | 7 | 2021 | 863 | 0.290 |
Why?
| | Cluster Analysis | 3 | 2019 | 30 | 0.280 |
Why?
| | Infant | 7 | 2021 | 1365 | 0.260 |
Why?
| | Electronic Health Records | 2 | 2021 | 53 | 0.260 |
Why?
| | Risk Assessment | 2 | 2020 | 135 | 0.250 |
Why?
| | Mediastinal Neoplasms | 1 | 2021 | 4 | 0.240 |
Why?
| | Anesthesia | 1 | 2021 | 4 | 0.240 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 5 | 0.240 |
Why?
| | Genetic Association Studies | 1 | 2021 | 33 | 0.230 |
Why?
| | Atrial Flutter | 1 | 2021 | 1 | 0.230 |
Why?
| | Leukemia | 1 | 2021 | 14 | 0.230 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 17 | 0.230 |
Why?
| | Botulinum Toxins | 1 | 2021 | 3 | 0.220 |
Why?
| | Neurotoxins | 1 | 2021 | 4 | 0.220 |
Why?
| | Ear, Inner | 1 | 2020 | 1 | 0.220 |
Why?
| | Labyrinth Diseases | 1 | 2020 | 1 | 0.220 |
Why?
| | Temporal Bone | 1 | 2020 | 1 | 0.220 |
Why?
| | Anatomic Variation | 1 | 2020 | 1 | 0.220 |
Why?
| | Hearing Loss | 1 | 2020 | 5 | 0.220 |
Why?
| | Diverticulum | 1 | 2020 | 4 | 0.220 |
Why?
| | Substance-Related Disorders | 1 | 2021 | 29 | 0.220 |
Why?
| | Environment Design | 1 | 2021 | 14 | 0.220 |
Why?
| | Respiration, Artificial | 1 | 2020 | 31 | 0.220 |
Why?
| | Enterocolitis | 1 | 2021 | 29 | 0.220 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 145 | 0.210 |
Why?
| | Child Development | 1 | 2020 | 46 | 0.210 |
Why?
| | Neonatal Nursing | 1 | 2020 | 2 | 0.210 |
Why?
| | Chorioamnionitis | 1 | 2020 | 4 | 0.210 |
Why?
| | Hirschsprung Disease | 1 | 2021 | 49 | 0.210 |
Why?
| | Echocardiography | 1 | 2020 | 58 | 0.210 |
Why?
| | Language Development | 1 | 2019 | 3 | 0.210 |
Why?
| | Child | 7 | 2021 | 2689 | 0.210 |
Why?
| | Conscious Sedation | 1 | 2019 | 1 | 0.210 |
Why?
| | Simulation Training | 1 | 2019 | 1 | 0.210 |
Why?
| | Waiting Lists | 1 | 2019 | 11 | 0.210 |
Why?
| | Cognition | 1 | 2019 | 28 | 0.200 |
Why?
| | Professional-Family Relations | 1 | 2019 | 12 | 0.200 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 12 | 0.200 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 3 | 0.200 |
Why?
| | Neonatology | 1 | 2019 | 10 | 0.200 |
Why?
| | Appointments and Schedules | 1 | 2019 | 13 | 0.200 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 67 | 0.200 |
Why?
| | Toll-Like Receptor 4 | 1 | 2019 | 14 | 0.200 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 98 | 0.200 |
Why?
| | Postoperative Complications | 1 | 2021 | 163 | 0.200 |
Why?
| | Crowdsourcing | 1 | 2019 | 1 | 0.200 |
Why?
| | Communication | 1 | 2019 | 43 | 0.200 |
Why?
| | Normal Distribution | 1 | 2018 | 2 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 81 | 0.190 |
Why?
| | Models, Statistical | 1 | 2018 | 29 | 0.190 |
Why?
| | Transcriptome | 1 | 2018 | 32 | 0.190 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 85 | 0.190 |
Why?
| | Lipoprotein(a) | 1 | 2018 | 1 | 0.190 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 8 | 0.190 |
Why?
| | Likelihood Functions | 1 | 2018 | 5 | 0.190 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 8 | 0.180 |
Why?
| | Parents | 1 | 2019 | 125 | 0.180 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 42 | 0.180 |
Why?
| | Health Behavior | 1 | 2018 | 71 | 0.180 |
Why?
| | Patient Readmission | 1 | 2018 | 70 | 0.180 |
Why?
| | Child, Preschool | 5 | 2020 | 1479 | 0.180 |
Why?
| | Patient Compliance | 1 | 2018 | 76 | 0.180 |
Why?
| | Respiratory Tract Infections | 1 | 2018 | 56 | 0.170 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 226 | 0.170 |
Why?
| | Myositis, Inclusion Body | 1 | 2016 | 1 | 0.160 |
Why?
| | Homeostasis | 1 | 2016 | 16 | 0.160 |
Why?
| | Proteins | 1 | 2016 | 22 | 0.160 |
Why?
| | Pediatric Obesity | 1 | 2018 | 111 | 0.160 |
Why?
| | Intensive Care Units, Neonatal | 3 | 2021 | 40 | 0.150 |
Why?
| | Age Factors | 2 | 2020 | 227 | 0.100 |
Why?
| | Cohort Studies | 2 | 2021 | 250 | 0.100 |
Why?
| | Gestational Age | 2 | 2020 | 82 | 0.100 |
Why?
| | Patient Discharge | 2 | 2021 | 53 | 0.100 |
Why?
| | Time Factors | 2 | 2020 | 276 | 0.100 |
Why?
| | Adolescent | 3 | 2020 | 1938 | 0.090 |
Why?
| | Infant, Premature | 2 | 2020 | 118 | 0.090 |
Why?
| | Databases, Factual | 2 | 2019 | 103 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 195 | 0.090 |
Why?
| | Clinical Trials as Topic | 2 | 2019 | 48 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 263 | 0.090 |
Why?
| | Mice | 2 | 2019 | 426 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2020 | 598 | 0.080 |
Why?
| | Adult | 2 | 2020 | 1075 | 0.080 |
Why?
| | Animals | 2 | 2019 | 861 | 0.070 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 2 | 0.060 |
Why?
| | Karyotyping | 1 | 2021 | 9 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 8 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 38 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2021 | 3 | 0.060 |
Why?
| | Standard of Care | 1 | 2021 | 5 | 0.060 |
Why?
| | Cities | 1 | 2021 | 9 | 0.060 |
Why?
| | Kansas | 1 | 2021 | 47 | 0.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 61 | 0.060 |
Why?
| | Audiometry | 1 | 2020 | 1 | 0.060 |
Why?
| | Phenotype | 1 | 2021 | 213 | 0.060 |
Why?
| | Recovery of Function | 1 | 2020 | 16 | 0.060 |
Why?
| | Chronic Disease | 1 | 2021 | 101 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2021 | 119 | 0.060 |
Why?
| | Incidence | 1 | 2021 | 132 | 0.060 |
Why?
| | Walking | 1 | 2021 | 31 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2021 | 35 | 0.050 |
Why?
| | Pandemics | 1 | 2021 | 41 | 0.050 |
Why?
| | Alleles | 1 | 2021 | 156 | 0.050 |
Why?
| | Infant, Extremely Premature | 1 | 2020 | 24 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2020 | 10 | 0.050 |
Why?
| | Weight Gain | 1 | 2020 | 23 | 0.050 |
Why?
| | Genotype | 1 | 2021 | 290 | 0.050 |
Why?
| | Prevalence | 1 | 2020 | 135 | 0.050 |
Why?
| | Digestive System Surgical Procedures | 1 | 2021 | 45 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 116 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2019 | 2 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2020 | 35 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2019 | 14 | 0.050 |
Why?
| | Professional Competence | 1 | 2019 | 2 | 0.050 |
Why?
| | Self-Assessment | 1 | 2019 | 4 | 0.050 |
Why?
| | Attitude | 1 | 2019 | 15 | 0.050 |
Why?
| | Exercise | 1 | 2021 | 102 | 0.050 |
Why?
| | Curriculum | 1 | 2019 | 19 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 16 | 0.050 |
Why?
| | Family | 1 | 2019 | 22 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2019 | 12 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 20 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2019 | 29 | 0.050 |
Why?
| | Cytokines | 1 | 2019 | 47 | 0.050 |
Why?
| | Pneumonia | 1 | 2019 | 30 | 0.050 |
Why?
| | Ireland | 1 | 2019 | 1 | 0.050 |
Why?
| | Italy | 1 | 2019 | 3 | 0.050 |
Why?
| | Organizations, Nonprofit | 1 | 2019 | 2 | 0.050 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2019 | 2 | 0.050 |
Why?
| | Machine Learning | 1 | 2019 | 11 | 0.050 |
Why?
| | Pregnancy | 1 | 2020 | 246 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 145 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 43 | 0.050 |
Why?
| | Protective Factors | 1 | 2018 | 7 | 0.050 |
Why?
| | Pulse Wave Analysis | 1 | 2018 | 2 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2018 | 2 | 0.050 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 5 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 2018 | 4 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2018 | 12 | 0.050 |
Why?
| | Oxygen | 1 | 2018 | 23 | 0.050 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 19 | 0.050 |
Why?
| | Self Report | 1 | 2018 | 36 | 0.050 |
Why?
| | Signal Transduction | 1 | 2019 | 147 | 0.050 |
Why?
| | Algorithms | 1 | 2019 | 95 | 0.050 |
Why?
| | Primary Health Care | 1 | 2018 | 43 | 0.050 |
Why?
| | Logistic Models | 1 | 2018 | 95 | 0.050 |
Why?
| | Missouri | 1 | 2018 | 90 | 0.050 |
Why?
| | Hypertension | 1 | 2018 | 54 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 253 | 0.050 |
Why?
| | United States | 1 | 2020 | 594 | 0.040 |
Why?
| | Hydroxylamines | 1 | 2016 | 1 | 0.040 |
Why?
| | Myoblasts | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Strength | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2016 | 3 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2016 | 2 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2016 | 3 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 3 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2016 | 8 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 10 | 0.040 |
Why?
| | Cell Survival | 1 | 2016 | 19 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2016 | 113 | 0.040 |
Why?
| | Rats | 1 | 2016 | 206 | 0.040 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|